83 related articles for article (PubMed ID: 18768351)
1. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy.
Umar S; Bax JJ; Klok M; van Bommel RJ; Hessel MH; den Adel B; Bleeker GB; Henneman MM; Atsma DE; van der Wall EE; Schalij MJ; van der Laarse A
Eur J Heart Fail; 2008 Sep; 10(9):878-83. PubMed ID: 18768351
[TBL] [Abstract][Full Text] [Related]
2. Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure.
Tarquini R; Guerra CT; Porciani MC; Michelucci A; Padeletti M; Ricciardi G; Chiostri M; Jelic S; Padeletti L
Cardiol J; 2009; 16(6):545-52. PubMed ID: 19950091
[TBL] [Abstract][Full Text] [Related]
3. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.
Orrego CM; Nasir N; Oliveira GH; Flores-Arredondo JH; Cordero-Reyes AM; Loebe M; Youker KA; Torre-Amione G
Congest Heart Fail; 2011; 17(3):140-6. PubMed ID: 21609388
[TBL] [Abstract][Full Text] [Related]
4. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.
Cabrera-Bueno F; García-Pinilla JM; Peña-Hernández J; Jiménez-Navarro M; Gómez-Doblas JJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa-Galván E
Europace; 2007 Sep; 9(9):757-61. PubMed ID: 17573358
[TBL] [Abstract][Full Text] [Related]
5. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.
van Bommel RJ; Bax JJ; Abraham WT; Chung ES; Pires LA; Tavazzi L; Zimetbaum PJ; Gerritse B; Kristiansen N; Ghio S
Eur Heart J; 2009 Oct; 30(20):2470-7. PubMed ID: 19717847
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin plasma levels predict left ventricular reverse remodeling after cardiac resynchronization therapy.
Morales MA; Maltinti M; Piacenti M; Turchi S; Giannessi D; Del Ry S
Pacing Clin Electrophysiol; 2010 Jul; 33(7):865-72. PubMed ID: 20230463
[TBL] [Abstract][Full Text] [Related]
8. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
[TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization therapy in mild heart failure.
Linde C
Europace; 2009 Nov; 11 Suppl 5():v72-6. PubMed ID: 19861394
[TBL] [Abstract][Full Text] [Related]
10. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
[TBL] [Abstract][Full Text] [Related]
11. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy.
Michelucci A; Ricciardi G; Sofi F; Gori AM; Pirolo F; Pieragnoli P; Giaccardi M; Colella A; Porciani MC; Di Biase L; Padeletti L; Abbate R; Gensini GF
J Card Fail; 2007 Apr; 13(3):207-10. PubMed ID: 17448418
[TBL] [Abstract][Full Text] [Related]
12. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
14. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
[TBL] [Abstract][Full Text] [Related]
15. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
[TBL] [Abstract][Full Text] [Related]
16. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
[TBL] [Abstract][Full Text] [Related]
17. Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels.
Hessel MH; Bleeker GB; Bax JJ; Henneman MM; den Adel B; Klok M; Schalij MJ; Atsma DE; van der Laarse A
Eur J Heart Fail; 2007 Oct; 9(10):1058-63. PubMed ID: 17728181
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
[TBL] [Abstract][Full Text] [Related]
19. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
20. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction.
Bertini M; Ziacchi M; Biffi M; Biagini E; Rocchi G; Martignani C; Ferlito M; Pasquale F; Cervi E; Branzi A; Rapezzi C; Boriani G
Heart; 2011 Feb; 97(4):295-300. PubMed ID: 21163889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
